PATENT CLAIM ANALYSIS

Application Number: 15753994
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["435", "006140"]

Abstract:
The object of the invention is to elucidate a new causative gene of cancer, polynucleotide, and thereby provide a method for detecting the polynucleotide or a polypeptide that is encoded by the polynucleotide, as well as a primer set or a detection kit for such detection. The detection method detects a fusion gene of a part of an RP2 gene and a part of an ARHGAP6 gene, or a fusion protein encoded by such gene. The primer set includes a sense primer designed from a section encoding RP2 and an antisense primer designed from a section encoding ARHGAP6.

Claim (Index 13):
A primer set for detecting a fusion gene composed of an RP2 gene and an ARHGAP6 gene existing in a sample obtained from a subject, the primer set comprising a sense primer designed from a section encoding RP2 and an antisense primer designed from a section encoding ARHGAP6 of the polynucleotide according to  claim 1 .

Metadata:
- Claim Count in Document: 23.0
- Percentile: 90.0
- Lexical Diversity: 2.1875
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15753775', '14383199', '13805513', '15113599', '14643181']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6015301929599769
- 35 USC 102 Novelty (BERT): 0.5377001949752116
- Combined Prediction Score: 0.5951471931615003
- Mean Citation Score: 345.207742
- Max Citation Score: 374.71338
- Similarity Product: 294.533744884758

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test